Today's

News

Stay informed about the latest developments and achievements from TRICALS. Here we will report about our progress and the accomplishments of our large scale collaboration. Browse and read the latest news to stay updated along our journey to find a treatment for ALS.

New centres in Portugal and Spain join TRICALS network
New centres in Portugal and Spain join TRICALS network
We are very excited to announce that recently two new expert ALS…
Stay in [u]touch[/u]

Stay in touch

Would you like to keep up to date with the latest news from TRICALS? Click on the button below to subscribe to our newsletter

Towards remote muscle strength measurements using a newly developed portable fixed dynamometer
Towards remote muscle strength measurements using a newly developed portable fixed dynamometer
Progressive muscle weakness is the hallmark of ALS. Evaluating muscle strength is…
Newsletter December 2020
Newsletter December 2020
2020 has been a difficult year for everyone. However, despite the many…
Reconsidering the ALSFRS-R for ALS clinical trials
Reconsidering the ALSFRS-R for ALS clinical trials
Questionnaires, such as the ALS Functional Rating Scale (ALSFRS), play an important…
Summary of the 31st International Symposium on ALS/MND
Summary of the 31st International Symposium on ALS/MND
Last week the 31st International Symposium on ALS/MND was held online. This…
Summary ENCALS Satellite meeting
Summary ENCALS Satellite meeting
In the run-up to the virtual 31st International Symposium on ALS/MND, the…
Dr Ruben van Eijk receives Paulo Gontijo Award 2020
Dr Ruben van Eijk receives Paulo Gontijo Award 2020
Dr Ruben van Eijk (UMC Utrecht) has been awarded the prestigious Paulo…
ENCALS Satellite Meeting 2020
ENCALS Satellite Meeting 2020
Tuesday December 8th at 15.30-17.30 CET, ENCALS and TRICALS will be sharing…
Webinar recording “Efficient Patient Identification in ALS Clinical Trials” now available
Webinar recording “Efficient Patient Identification in ALS Clinical Trials” now available
Two weeks ago, we presented the free webinar: "Efficient Patient Identification in…
The ALXN1210 trial is recruiting participants
The ALXN1210 trial is recruiting participants
This phase 3 trial, which is sponsored by Alexion Pharmaceuticals, aims to…